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Different IgE recognition of mite allergen components
in asthmatic and nonasthmatic children
Yvonne Resch, MSc,a Sven Michel, MSc,b Michael Kabesch, MD,b Christian Lupinek, MD,a Rudolf Valenta, MD,a and
Susanne Vrtala, PhDa,c Vienna, Austria, and Regensburg, GermanyBackground: House dust mites (HDMs) represent one of the
most important inducers of respiratory allergies worldwide.
Objective: We sought to investigate the IgE and IgG reactivity
profiles to a comprehensive panel of HDM allergens in children
with allergic asthma and to compare them with those of
nonasthmatic atopic children.
Methods: Sera from clinically well-characterized asthmatic
children with HDM allergy (n5 105), nonasthmatic children
(n 5 53), and nonatopic nonasthmatic children (n5 53) were
analyzed for IgE and IgG reactivity to a panel of 7HDMallergens
(nDer p 1, rDer p 2, rDer p 5, rDer p 7, rDer p 10, rDer p 21, and
rDer p 23) by means of allergen microarray technology.
Results: Asthmatic children with HDM allergy more frequently
showed an IgE response to each of the HDM allergens and
recognized more allergens than nonasthmatic children with
HDM allergy. Furthermore, IgE levels to certain HDM
allergens (nDer p 1, P 5 .002; rDer p 2, P 5 .007; rDer p 5,
P 5 .031; and rDer p 23, P < .001) were significantly higher in
asthmatic children than in children without asthma. By
contrast, fewer asthmatic children showed IgG reactivity to
HDM allergens than nonasthmatic children, but allergen-
specific IgG levels were comparable.
Conclusion: The IgE and IgG reactivity profiles to HDM
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http://dx.doi.org/10.1016/j.jaci.2015.03.024differed considerably between children with and without
asthmatic symptoms caused by HDM allergy. In fact, asthmatic
children were characterized by an expanded IgE repertoire
regarding the numbers of recognized allergen components and
by increased specific IgE levels. (J Allergy Clin Immunol
2015;136:1083-91.)
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Exposure and atopic sensitization to indoor allergens, such as
those from pets, molds, cockroaches, and house dust mites
(HDMs), are known to be strongly associated with the
development of asthma.1-3 The association between asthma and
house dust was reported in 1921 by Kern,4 who showed that
many asthmatic patients had strongly positive skin test
responses to house dust. Since 1967, when mites of the genus
Dermatophagoides were determined to be a major allergen-
producing source in house dust,5 many studies have confirmed
the importance of HDM allergy as a major risk factor for
asthma.6-8 In fact, up to 85% of asthmatic patients are allergic
to Dermatophagoides pteronyssinus, Dermatophagoides farinae,
or both,9 which are the 2 most important HDM species.10
Moreover, it has been reported that high IgE antibody titers to
HDM allergen extracts were common and increased the risk for
acute wheezing among asthmatic children.11
Since 1980, when the first allergen was described for
D pteronyssinus,12 the molecular structures of several HDM
allergens have been identified, including a recently described
new major HDM allergen, Der p 23.13,14 With the availability
of a comprehensive set of HDM allergens, it is now possible to
study molecular reactivity profiles that might be associated with
certain manifestations of HDM-induced allergic symptoms.
A study using recombinant allergen molecules to investigate
potential differences in adults and children with various
respiratory manifestations of HDM-associated respiratory allergy
indicated lower allergen-specific IgG antibody levels in children
with asthma exacerbations.15
The Immuno Solid-phase Allergen Chip (ImmunoCAP ISAC;
Thermo Fisher Scientific, Uppsala, Sweden) technology allows
determination of a patient’s IgE and IgG reactivity profile to a
large number of natural and recombinant allergens in a single step
by using only minimal amounts of serum.16 Comparison of the
ImmunoCAP ISAC with other techniques of allergen-specific
IgE determinations, such as ImmunoCAP, showed similar diag-
nostic performances.17-19 Several studies have shown the
usefulness of the chip technology for detecting allergen-specific
IgE,18 longitudinally assessing IgE reactivity profiles,20 guiding
the prescription of specific immunotherapy,21 analyzing
allergen-specific IgE and IgG responses in parallel,22 analyzing
IgE reactivity in children and adults,23 monitoring IgE reactivities1083
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The currently available ImmunoCAP ISAC 112 is able to
detect IgE and IgG against 112 different allergens, including the
D pteronyssinus allergens Der p 1, Der p 2, and Der p 10. To
perform a more profound analysis of sera from patients with
HDM allergy, we used the ImmunoCAP ISAC technology to
produce an experimental allergen chip, which contains an
extended panel of HDM allergens (ie, Der p 1, Der p 2, Der p 5,
Der p 7, Der p 10, Der p 21, and Der p 23). This microarray
was used to measure IgE and IgG responses in 2 groups of
clinically well-defined children with HDM allergy with or
without HDM-induced asthma and, for control purposes, a group
of nonatopic children.METHODS
Subjects
Sera from 105 allergic children with HDM-associated asthma were
randomly picked from the Multicentre Asthma Genetics in Childhood study.
This group was termed asthmatic children with HDM allergy. Sera from 53
children with HDM allergy but without asthma were randomly picked from
the International Study of Asthma and Allergies in Childhood Phase II
population as age- and sex-matched nonasthmatic group. The latter group was
termed nonasthmatic children with HDM allergy. From the same study
population, sera from 53 nonatopic children (no allergic symptoms and
negative skin prick test responses) were randomly picked. The combined use
of both study cohorts (Multicentre Asthma Genetics in Childhood and
International Study of Asthma and Allergies in Childhood Phase II) and
previous allergy testing has been described earlier.26-28 A description of the
criteria for patient selection can be found in the Methods section in this
article’s Online Repository at www.jacionline.org. Table I summarizes the
demographic, serologic, and clinical data of the 3 groups. Anonymized sera
were sent to Vienna, where the analyses were retrospectively performed in a
blinded manner with permission from the Ethics Committee of the Medical
University of Vienna.Natural and recombinant HDM allergens
nDer p 1 was purified by means of affinity chromatography with mAb
4C1.29 rDer p 2 was expressed in Escherichia coli as a His-tagged protein and
purified, as previously described.30 rDer p 5, rDer p 7, rDer p 10, rDer p 21, and
rDer p 23 were expressed in E coli as nonfusion proteins and purified to
homogeneity by using ion exchange chromatography, as previously
described.14,31-33 The proteins were stored at 2208C until use.ImmunoCAP ISAC microarray
For the analysis of the sera from the nonasthmatic and asthmatic groups, a
customized version of the ImmunoCAP ISAC microarray termed CD chip
(Thermo Fisher Scientific, Uppsala, Sweden) containing a panel of D ptero-
nyssinus allergens (ie, nDer p 1, rDer p 2, rDer p 5, rDer p 7, rDer p 10,
rDer p 21, and rDer p 23) and several other allergens and allergen-derived pep-
tides (see Table E1 in this article’s Online Repository at www.jacionline.org)
was produced. Detection of IgE and IgG binding was performed according to
the manufacturer’s instructions for ISAC 112, with slight modifications.
Washing steps were done exclusively with washing solution (no secondwashing step with water), and the chips were dried by means of centrifugation
(1minute at 1000g andRT). Levels of allergen-specific IgE and IgG antibodies
were reported in ISAC standardized units (ISU) with a cutoff of 0.3 ISU. The
allergen-specific IgE and IgG levels of the sera from the 53 nonatopic children
were tested with the MeDALL allergen chip, which equals the CD chip in
technical aspects but comprises additional allergens.34Basophil activation tests
Rat basophil leukemia cells (RBL-2H3)35 transfected with human FcεRI
were sensitized with sera from asthmatic children with HDM allergy (dilution
1:10). Cell degranulationwas induced by adding 3 different concentrations (ie,
10, 1, and 0.1 ng/mLof each allergen) of 2 HDMallergenmixes (mix 1: nDer p
1 and rDer p 2; mix 2: nDer p 1, rDer p 2, rDer p 5, rDer p 7, rDer p 21, and
rDer p 23) or buffer as a control. b-Hexosaminidase release was measured, as
previously described.36Statistics
IBM SPSS Statistics 20 (SPSS, Chicago, Ill) was used for evaluating the
following statistical parameters. Differences in IgE- and IgG-binding
frequencies of asthmatic, nonasthmatic, and nonatopic children with HDM
allergy were assessed by using multiple x2 testing or the Fisher exact test,
depending on the number of observations. Differences in IgE and IgG levels
among the 3 groups were analyzed with the Mann-Whitney U test. The
correlation between IgE and IgG reactivity to the allergens was evaluated
by calculating the Spearman rank correlation coefficient (r). A P value of
less than .05 was considered statistically significant.RESULTS
Asthmatic children with HDM allergy more
frequently have an IgE response to each of the HDM
allergens and recognize more allergens than
nonasthmatic children with HDM allergy
We found that 149 (94.3%) of the 158 analyzed children with
HDM allergy had IgE reactivity to at least one of the 7 spotted
HDM allergens (nDer p 1, rDer p 2, rDer p 5, rDer p 7, rDer p 10,
rDer p 21, and rDer p 23). With a combination of nDer p 1 and
rDer p 2, 89% of the patients were diagnosed (see Fig E1 in this
article’s Online Repository at www.jacionline.org). Sera from 8
children with negative chip results could be tested by means of
IgE immunoblotting to D pteronyssinus allergen extract, and 7
showed very weak IgE reactivity (data not shown). Twenty-one
percent of the patients were exclusively sensitized to nDer p 1,
rDer p 2, or both. Interestingly, 18 children with HDM allergy
reacted neither with nDer p 1 nor with rDer p 2. Six of these
patients showed an exclusive sensitization to rDer p 23 but not
to the other tested HDM allergens (see Fig E1). With a
combination of nDer p 1, rDer p 2, and rDer p 23, 92.4% of the
patients were identified, and only 2 patients showed exclusive
sensitization to other tested HDM allergens (see Fig E1). nDer
p 1 was the most frequently recognized allergen (nonasthmatic
patients, 74%; asthmatic patients, 77%), followed by rDer p 2
(60% and 81%, respectively) and rDer p 23 (59% and 71%,
respectively; Fig 1, A). rDer p 5 (nonasthmatic patients, 13%;
asthmatic patients, 39%), rDer p 7 (19% and 37%, respectively),
and rDer p 21 (15% and 29%, respectively) were less frequently
recognized, and only a few patients had IgE reactivity to rDer p 10
(0% and 2% respectively; Fig 1, A). In the nonatopic group only 2
children had weak IgE reactivity, one to nDer p 1 (0.37 ISU) and
one to rDer p 2 (2.11 ISU), whereas the remaining 51 had no IgE
reactivity to any of the 7 tested HDM allergens (data not shown).
TABLE I. Demographic, serologic, and clinical characterization of the study population
Nonatopic subjects Nonasthmatic subjects Asthmatic subjects
Male Female Total Male Female Total Male Female Total
Patients, no. (%) 25 (47) 28 (53) 53 (100) 25 (47) 28 (53) 53 (100) 50 (47) 55 (53) 105 (100)
Age range (y [minimum-maximum]) 9-11 9-11 9-11 9-12 9-11 9-12 7-17 7-16 7-17
Mean age (y) 9.68 9.61 9.64 9.76 9.71 9.74 10.68 10.36 10.5
Mean total IgE (kU/L) 78.77 163.72 121.24 363.8 315.1 338.5 659.5 901.9 786.4
>1 Hospital visit in last 12 mo due to asthma, no. (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 22 (44.0) 21 (38.2) 43 (41.0)
>3 Hospital visits in last 12 mo due to asthma, no. (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 9 (18.0) 8 (15.5) 17 (16.2)
Atopic dermatitis, no. (%) 0 (0) 0 (0) 0 (0) 4 (16.7) 6 (22.2) 10 (18.9) 27 (56.3) 27 (50) 54 (51.4)
Sensitization to other respiratory allergens
Cat, no. (%) 0 (0) 0 (0) 0 (0) 13 (52.0) 15 (53.6) 28 (53) 28 (56.0) 38 (69.1) 66 (63)
Grass pollen, no. (%) 0 (0) 0 (0) 0 (0) 18 (72.0) 20 (71.4) 38 (72) 36 (72.0) 41 (74.5) 77 (73)
Tree pollen, no. (%) 0 (0) 0 (0) 0 (0) 8 (32.0) 13 (46.2) 21 (40) 30 (60.0) 30 (54.5) 60 (57)
FIG 1. IgE reactivity of asthmatic and nonasthmatic children with HDM
allergy to individual HDM allergens. A, IgE binding prevalences (y-axis:
percentage) to the allergens as measured with ImmunoCAP ISAC
technology for nonasthmatic (white bars) and asthmatic (gray bars)
children with HDM allergy. Significant differences between the 2 groups
are shown. *P < .05 and **P < .01. B, Number of HDM allergens (x-axes)
recognized by nonasthmatic (left panel) or asthmatic (right panel) children
with HDM allergy (y-axes: percentages of IgE-reactive patients).Gray boxes
denote numbers of allergens recognized by 74% and 70% of the
nonasthmatic and asthmatic children, respectively.
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allergens differed considerably between children with HDM
allergy with and without asthma. rDer p 2, rDer p 5, and rDer p
7 were significantly more often recognized by asthmatic patients
(rDer p 2, P 5 .005; rDer p 5, P 5 .001; and rDer p 7, P 5 .019;
Fig 1,A). Interestingly, rDer p 5 was 3-fold more often recognized
by asthmatic than nonasthmatic children.
Accordingly, we found that the sum of IgE reactivities to HDM
components was significantly higher in the asthmatic than in the
nonasthmatic group (asthmatic mean, 67.9 ISU; nonasthmatic
mean, 26.7 ISU; P < .001), which was also reflected by a
significant difference in total IgE levels between the groups
(asthmatic mean, 786 kU/L; nonasthmatic mean, 338 kU/L;P < .001; Table I). Neither in the asthmatic group nor in the
nonasthmatic group were statistically significant sex-related
differences found regarding the frequency of IgE recognition of
the tested HDM allergens or allergen-specific IgE levels (data
not shown). There was also no correlation between age and the
number of recognized allergens (all children, r 5 0.137,
P5 .086; nonasthmatic children, r5 0.007, P5 .961; asthmatic
children, r 5 0.119, P 5 .228). Finally, we checked whether
different sensitization profiles in the groups could be due to
differences regarding time points of blood sampling in the seasons
of the year, but there were no significant differences (multiple x2
testing: spring, P 5 .136; summer, P 5 .061; autumn, P 5 .462;
winter, P5 .432), especially not for autumn, where HDM burden
is highest in middle Europe.37,38
Calculation of the odds ratio (OR) showed that patients with
IgE reactivity to rDer p 5 have a more than 4-fold higher risk of
asthma than patients without IgE reactivity to rDer p 5 (OR, 4.21;
95% CI, 1.74-10.22; P 5 .0015). Furthermore, the risk of being
asthmatic was more than 2-fold higher in patients with IgE
reactivity to rDer p 2 (OR, 2.79; 95% CI, 1.34-5.82; P 5 .006)
and patients with IgE reactivity to rDer p 7 (OR, 2.54; 95% CI,
1.15-5.62; P 5 .021), respectively. The calculated ORs for the
other HDM allergens (nDer p 1, rDer p 10, rDer p 21, and rDer
p 23) were statistically not significant.
The positive predictive value, providing information about the
probability that a positive test result correctly indicates that a
certain symptom (ie, asthma) is present, was calculated for the
individual allergens. Patients with IgE reactivity to rDer p 5 had a
probability of 85% of having asthma. In addition, high positive
predictive values were found for rDer p 7 (80%) and rDer p 21
(79%). However, the sensitivities for each of the allergens were
low: rDer p 5, 39%; rDer p 7, 37%; and rDer p 21, 29%. The
sensitivity could be increased to 57% when the latter 3 allergens
were combined.
Another interesting finding was that asthmatic children with
HDM allergy had IgE reactivity to more HDM allergens than
nonasthmatic children (Fig 1, B). Seventy percent of the children
in the asthma group reacted to 3 to 6 of the tested allergens,
whereas approximately the same percentage (74%) of
nonasthmatic children had IgE reactivity only to 1 to 3 HDM
allergens (Fig 1, B, gray boxes). No IgE reactivity was found to
several of the unrelated food allergens and food allergen–derived
peptides that were part of the array in any of the tested patients
ensuring specificity (data not shown).
FIG 2. IgE levels to individual HDM allergens. Specific IgE levels (in ISU, y-axis) to HDM allergens (x-axis)
determined for reactive children with HDM allergy with (A, right columns) and without (NA, left columns)
asthma are displayed as scatter plots. The number of IgE-positive sera for the individual allergens are dis-
played below. Statistically significant differences between the 2 groups are indicated. *P < .05 and **P < .01.
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IgE levels to HDM allergens than children with HDM
allergy but without asthma
Levels of allergen-specific IgE antibodies in children with
HDM allergy were highest for rDer p 2 (medians: all, 15.1 ISU;
asthmatic children, 19.9 ISU; nonasthmatic children, 11.4 ISU),
followed by rDer p 5 (medians: all, 13.1 ISU; asthmatic children,
16.5 ISU; nonasthmatic children, 4.7 ISU) and nDer p 1 (medians:
all, 13.1 ISU; asthmatic children, 15.3 ISU; nonasthmatic
children, 8.6 ISU; Fig 2). Striking differences were found
between HDM-allergic children with and without asthma. Asth-
matic children with HDM allergy had higher IgE levels to each
of the tested HDM allergens than nonasthmatic children. In
particular, IgE levels to nDer p 1 (P 5 .002), rDer p 2
(P 5 .007), rDer p 5 (P 5 .031), and rDer p 23 (P < .001) were
significantly higher in children with HDM allergy with asthma
than in those without (Fig 2).An allergen mix comprising all respiratory HDM
allergens induces stronger basophil activation than
a mix containing only Der p 1 and Der p 2
Basophil activation tests were performed to study whether
sensitization to a larger number of HDM allergens and increased
HDM-specific IgE levels might also have functional relevance.
RBL cells expressing the human FcεRI receptor were loaded with
serum IgE from 13 asthmatic children from whom serum was
available and who were sensitized against a broad spectrum of
HDM allergens. Then cells were exposed either to a mix
containing only nDer p 1 and rDer p 2 or to a mix containing
Der p 1, 2, 5, 7, 21, and 23. At a concentration of 1 ng/mL (ie,
increasing part of the dose response curve), the mix containing all
allergens induced a significantly higher release of b-hexosamin-
idase (mean relative increased release, 46%) than the mix
containing only nDer p 1 and rDer p 2 in 11 of the 13 patients
(see Fig E2 in this article’s Online Repository at www.jacionline.
org).Fewer asthmatic children with HDM allergy have
IgG reactivity to HDM allergens than nonasthmatic
children with HDM allergy, but allergen-specific IgG
levels were comparable
The IgG recognition frequency of HDM allergens was very
high in patients with HDM allergy, as well as in nonatopic
subjects (Fig 3 and see Fig E3 in this article’s Online Repository at
www.jacionline.org). The highest IgG-binding frequencies
(100%) were found for rDer p 5 and rDer p 10 in the nonasthmatic
group, as well as for nDer p 1, rDer p 7, and rDer p 21 in the
nonatopic children. Interestingly, no patient from the
nonasthmatic group had shown IgE reactivity to rDer p 10.
Although the IgG-binding frequencies were comparable
between nonasthmatic and nonatopic children, the group of
asthmatic children with HDM allergy had lower IgG-binding
frequencies to most of the HDM allergens compared with the
other 2 groups (nDer p 1: 75% vs 81% and 100%; rDer p 2: 92%vs
94% and 87%; rDer p 5: 77% vs 100% and 94%; rDer p 7: 77% vs
98% and 100%; rDer p 10: 89% vs 100% and 96%; rDer p 21:
81% vs 96% and 100%; and rDer p 23: 85% vs 94% and 98%).
Statistically significant differences among the 3 groups are
indicated in Fig 3.
We then analyzed the percentages of sera containing IgE and
IgG antibodies, only IgG, only IgE or neither IgE nor IgG
antibodies specific for each of the HDM allergens (Fig 4). There
were more only IgG-positive sera in the nonasthmatic group,
whereas only IgE-positive sera were found only in the asthmatic
group, which also contained more sera that were IgE and IgG
negative to each of the HDM allergens except Der p 1 (Fig 4).
When patients were grouped into those who only had allergen-
specific IgG without specific IgE or those with allergen-specific
IgE and IgG antibodies, we noted that for most allergens,
allergen-specific IgG levels were significantly higher in the latter
group (Fig 5). Although fewer asthmatic children had IgG
reactivity to the HDM allergens compared with the nonasthmatic
children (Fig 3), there were no relevant differences regarding IgG
levels specific for each of the tested allergens, regardless of
FIG 3. Frequencies of IgG reactivities to individual HDM allergens in asthmatic and nonasthmatic children
with HDM allergy, as well as nonatopic subjects. IgG-binding frequencies (y-axis: percentages) to the aller-
gens (x-axis) are shown for nonatopic (light gray), nonasthmatic (white bars), and asthmatic (dark gray bars)
patients with HDM allergy. Statistically significant differences between the groups are indicated. **P < .01.
FIG 4. Percentages of sera with certain IgE and IgG reactivity profiles to HDM allergens. Displayed are
percentages (y-axes) of sera among the group of asthmatic and nonasthmatic children with HDM allergy
containing only IgE (violet), IgE and IgG (green), only IgG (red) or neither IgE nor IgG (blue) to each of
the allergens (x-axes).
J ALLERGY CLIN IMMUNOL
VOLUME 136, NUMBER 4
RESCH ET AL 1087whether patients with only positive IgG results or patients with
both positive IgE and positive IgG results were analyzed. Only
for nDer p 1 and rDer p 10 were the IgG levels in the only IgG-
positive groups different between asthmatic and nonasthmatic
children (nDer p 1, P 5 .019; rDer p 10, P 5 .014; Fig 5).
Significantly lower HDM allergen-specific IgG levels were
found in the nonatopic children compared with the asthmatic and
nonasthmatic groups with HDM allergy for all allergens
except rDer p 23 (see Fig E4 in this article’s Online Repository
at www.jacionline.org).Allergen-specific IgE and IgG reactivities are only
partially correlated
Next, we assessed correlations between IgE and IgG
reactivities and levels in sera from the children with HDM allergy
to the 7 tested HDM allergens (Fig 6 and see Figs E1 and E3).
Figs E1 and E3 show that several asthmatic children lacked
allergen-specific IgG but mounted allergen-specific IgE
responses (nDer p 1: patients 75, 77, 78, 83, 91, 92, 97, and
101; rDer p 5: patients 32, 46, 95, and 98; rDer p 7: patients 17,40, 75, and 95; rDer p 21: patients 64 and 95; rDer p 23: patients
18, 57, 66, 75, 78, and 95). The partial dissociation of allergen-
specific IgE and IgG responses became also apparent when
allergen-specific IgE and IgG levels were correlated (Fig 6). In
the nonasthmatic group significant correlations between
allergen-specific IgE and IgG levels were found only for rDer p
2 (r 5 0.80, P < .001) and nDer p 1 (r 5 0.79, P < .0001). The
correlations were less pronounced for rDer p 23 (r 5 0.66,
P < .001) and rDer p 7 (r 5 0.42, P 5 .002) and only very
weak for rDer p 21 (r 5 0.27, P 5 .055) and rDer p 5
(r 5 0.25, P 5 .076). None of the patients with HDM allergy
without asthma had IgE reactivity to rDer p 10, but all had IgG
reactivity (Fig 6). Notably, rDer p 10–specific IgG levels were
very high. Only rDer p 2–specific IgG levels were higher than
rDer p 10–specific IgG levels (Fig 5).
In agreement with the fact that fewer asthmatic patients had
allergen-specific IgG responses and higher levels of allergen-
specific IgE in the asthma group, the correlation between
allergen-specific IgE and IgG levels was weaker for the asthmatic
group than for the group of nonasthmatic subjects for most of the
tested allergens (nDer p 1: r5 0.69,P <.0001; rDer p 2: r5 0.64,
FIG 5. Comparison of allergen-specific IgG levels in nonasthmatic and asthmatic children with HDM allergy
containing only allergen-specific IgG or allergen-specific IgE and IgG. Specific IgG levels (y-axes) are
displayed for each of the HDM allergens (x-axes) for the nonasthmatic (NA, left columns) and asthmatic
(A, right columns) groups. Medians are indicated, and significant differences between only IgG-positive
(red diamonds) and IgE- and IgG-positive (green circles) sera are indicated by asterisks. **P < .01. Signifi-
cant differences between nonasthmatic and asthmatic children in the IgG levels in the only IgG-positive
groups (for Der p 1 and Der p 10) are indicated (blue asterisks). *P < .05.
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P 5 .502; and rDer p 23: r 5 0.53, P < .001). Only for rDer p 5
(r 5 0.45, P < .001) and rDer p 21 (r 5 0.47, P < .001) was the
correlation higher in the asthma group (Fig 6). However, several
children from the asthmatic and nonasthmatic groups mounted
high allergen-specific IgE levels, as well as high IgG levels
(see Fig E3, marked by x).DISCUSSION
In this study we used a panel of 7 microarrayed HDM allergens
to study possible differences in IgE and IgG recognition in
clinically well-defined children with HDM allergy with or
without allergic asthma. Our study revealed interesting
differences regarding IgE recognition in these 2 groups.
Asthmatic children with HDM allergy showed a more broadly
spread recognition of different allergens, as well as higher
allergen-specific IgE levels, compared with the nonasthmatic
group.
Both high IgE levels and broad recognition of HDM allergens
should lead to dense loading of mast cells, basophils, and also
antigen-presenting cells with allergen-specific IgE through their
IgE receptors and render such patients more sensitive to allergen
exposure. In fact, earlier studies performed by measuring
HDM-specific IgE levels with allergen extracts also showed
that high levels of HDM-specific IgE antibodies are associated
with reduced lung function and increased risk of wheezing.11,39
However, these studies were performed with allergen extracts
and therefore did not provide information regarding numbers of
recognized allergens. The possibility of analyzing IgE reactivities
to a large panel of different allergens with small amounts of
serum is a strength of the ImmunoCAP ISAC chip technology.
ImmunoCAP ISAC technology also offers high sensitivity,
specificity, and good performance regarding intra-assay and
interassay variation.34 However, it must be borne in mind thatresults depend on the use of high-quality allergen preparations,
the coupling must be optimized for each of the components,
and because of the low amount of allergen on the solid phase,
IgG might compete with IgE binding, leading to lower IgE
signals.34
One novel aspect of our study is the demonstration that
asthmatic children compared with nonasthmatic children were
more often sensitized against several allergens, among them the
major allergen rDer p 2 and rDer p 5, rDer p 7, and rDer p 21,
which were shown to be potent allergens regarding the elicitation
of immediate-type allergic reactions.32,40 The lower prevalence of
IgE reactivity to rDer p 2 in our study compared with another
study41 might be explained by geographic differences, as has
already been shown by Weghofer et al.42
The finding that a mix comprising Der p 1, 2, 5, 7, 21, and 23
induced stronger basophil activation in polysensitized patients
than a mix comprising only Der p 1 and Der p 2 suggests that
polysensitizationmight eventually have functional consequences,
but this needs to be investigated in clinical studies.
The fact that the IgE response of the asthmatic children was
more broadly spread toward several different allergen molecules
compared with that of the nonasthmatic children did not seem to
be due to different immunogenicity of the individual allergens in
the 2 patient groups. On the contrary, we found an inverse
situation for allergen-specific IgG recognition in the 2 groups.
Nonasthmatic children evenmore often had IgG reactivity against
the individual allergens compared with asthmatic children.
Therefore there are several mutually nonexclusive possibilities
concerning why asthmatic children have IgE reactivity to more
HDM allergens and produce higher allergen-specific IgE levels
compared with nonasthmatic children. One possibility is that
certain HDM allergens, such as the cysteine protease Der p 1,
could act as a kind of ‘‘initiator allergen’’ by disrupting tight
junctions, thus reducing epithelial barrier function and leading to
increased intrusion of sensitizing allergens.43 It is also possible
FIG 6. Correlations between IgE (x-axes) and IgG (y-axes) antibody levels to individual allergens for
nonasthmatic (left panels) and asthmatic (right panels) children with HDM allergy are displayed as scatter
plots. IgE- and/or IgG-negative values are depicted as 0.15 ISU (half of the cutoff value) to allow a log-scale
presentation of the data. The correlation coefficient r and levels of significance (P values) are shown in the
lower right corner of the graphs.
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them capable of pushing the innate immune system toward a
TH2 pathway.
44,45 Furthermore, allergic patients who are
predisposed to asthma might exhibit intrinsic features, such as
epithelial barrier defects, increased atopic predisposition, or
both, that render them more susceptible to allergic sensitiza-
tion.46,47 The net result of these mechanisms would be a more
frequent and more intense IgE recognition of individual allergens
present in a complex allergen source, such as HDM, which ispreferentially associated with asthma, whereas sensitization to
fewer allergens is more related to rhinitis. It has been suggested
that children might acquire additional IgE sensitizations with
increasing age,24 and it is therefore possible that the fact that
asthmatic children reacted with more HDM allergens could be
due to a bias toward higher age in this group. However, when
we correlated the children’s age with the number of recognized
allergens, we found no correlation between age and the number
of recognized allergens. In addition to age, we studied also
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might have had an effect on IgE recognition profiles in the
asthmatic and nonasthmatic groups, but no significant differences
regarding blood sampling in the 4 seasons were found in the
groups.
Because the asthmatic children had significantly higher
HDM-specific IgE levels, it was not surprising to find that they
exhibited also higher total IgE levels compared with the
nonasthmatic group because it is known that most of the total
IgE consists of allergen-specific IgE.48,49
Regarding the naturally occurring allergen-specific IgG
responses, we noted that for each of the tested allergens, with
the exception ofDer p 10, allergen-specific IgG levels were higher
in patients who also produced allergen-specific IgE against the
same allergen. This observation might be explained by different
routes of sensitization because Der p 1, Der p 2, Der p 5, Der p 7,
Der p 21, and Der p 23 are mainly present in fecal particles and
hence could sensitize preferentially through the respiratory tract,
yielding stronger and more frequent IgE responses. By contrast,
Der p 10 is mainly present in mite bodies and hence can sensitize
through the skin or gut by involving cross-reactivity with
homologous food allergens.50 Thus Der p 10–specific IgG
responses might also result from contact with cross-reactive
food allergens, such as tropomyosins from seafood. For most of
the HDM allergens, the frequency of IgG reactivity was
comparable between the nonatopic and atopic nonasthmatic
children, but IgG levels were lowest for the nonatopic children.
A limitation of our study is that no data regarding allergen
exposure were available, and therefore we can only speculate
about whether lower exposure, lower immunogenicity, or both
of the HDM allergens might have caused differences in HDM
allergen–specific IgE and IgG responses.
In summary, this study has revealed that the assessment of IgE
and IgG reactivities toward a comprehensive panel of HDM
allergen components defines complex serologic reactivity profiles
that might help to discriminate asthmatic and nonasthmatic
children. It will now be interesting to perform longitudinal studies
in birth cohorts to answer the question of whether such
multiallergen tests might be able to predict the development
and eventually persistence of asthma.51,52
We thank Sandra Scheiblhofer and Josef Thalhamer for providing us with
the RBL cell line expressing human FcεRI.
Clinical implications: IgE sensitization to a broad panel of
HDM allergens and high IgE levels to certain components are
associated with allergy affecting the lower airways in children
with HDM allergy.REFERENCES
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